These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21160206)

  • 1. The role of nanobiotechnology in the development of personalized medicine.
    Jain KK
    Med Princ Pract; 2011; 20(1):1-3. PubMed ID: 21160206
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanobiotechnology and personalized medicine.
    Jain KK
    Prog Mol Biol Transl Sci; 2011; 104():325-54. PubMed ID: 22093223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nanobiotechnology in drug discovery.
    Jain KK
    Drug Discov Today; 2005 Nov; 10(21):1435-42. PubMed ID: 16243263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems.
    Crommelin DJ; Storm G; Luijten P
    Int J Pharm; 2011 Aug; 415(1-2):5-8. PubMed ID: 21320581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nanobiotechnology in the personalized management of glioblastoma multiforme.
    Jain KK
    Nanomedicine (Lond); 2011 Apr; 6(3):411-4. PubMed ID: 21542679
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of nanobiotechnology in the development of personalized medicine.
    Jain KK
    Nanomedicine (Lond); 2009 Apr; 4(3):249-52. PubMed ID: 19331532
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A challenging drug development process in the era of personalized medicine.
    Jørgensen JT
    Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legal developments and practical implications of gene patenting on targeted drug discovery and development.
    Klein RD
    Clin Pharmacol Ther; 2010 Jun; 87(6):633-5. PubMed ID: 20485317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
    Chackalamannil S; Desai MC
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine.
    Bawa R
    IDrugs; 2007 Jul; 10(7):455-8. PubMed ID: 17642014
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of nanobiotechnology in developing personalized medicine for cancer.
    Jain KK
    Technol Cancer Res Treat; 2005 Dec; 4(6):645-50. PubMed ID: 16292884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting the technical challenges of personalized medicine and companion diagnostics.
    Montagna RA
    MLO Med Lab Obs; 2012 Jan; 44(1):16, 18, 20 passim. PubMed ID: 22352180
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combat against cancer with science and medicine.
    Chow LW; Toi M
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S3-4. PubMed ID: 20374027
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploring emerging nanobiotechnology drugs and medical devices.
    Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
    Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarkers and personalized psychiatry.
    Roffman JL
    Harv Rev Psychiatry; 2011; 19(3):99-101. PubMed ID: 21631156
    [No Abstract]   [Full Text] [Related]  

  • 20. A piece in the puzzle of personalized medicine.
    Kroemer HK; Meyer zu Schwabedissen HE
    Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.